Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IGEN International -- Ignore unavailable to you. Want to Upgrade?

To: jpbrody who wrote (446)	4/29/1999 1:04:00 AM
From: jpbrody	Read Replies (1) \| Respond to of 1025

Does anyone know which Roche products Igen is supposed to receive royalties for? I know Electsys is one of them, but what about the Cobas line. The Roche annual report is online: ir.roche.com Here's what they say about the diagnostics division: Sales of immunodiagnostic products outpaced the market for the fifth consecutive year. Continuous efforts to improve and expand the unit's reagent menus by adding important new diagnostic parameters led to significant sales gains for the Roche/Hitachi and Cobas Integra lines. Demand was also buoyant for the Elecsys and Cobas Core lines. Increased sales of the Elecsys analyser were spurred in part by the addition of assays for infectious diseases. -- Jim